Alpha 2.0
Login Register
» Articles » PMID: 29249304

CAR T-cell Therapy in Refractory Large B-cell Lymphoma

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2017 Dec 19
PMID 29249304
Citations 12
Authors
Robert Stirrups
Affiliations
Soon will be listed here.
Citing Articles

The Unprecedented Success of Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Hematological Malignancies.

Dhaliwal S, Gill F, Hamid P Cureus. 2024; 16(5):e59951.

PMID: 38854249 PMC: 11162278. DOI: 10.7759/cureus.59951.

CAR-T cell therapy for hematological malignancies: History, status and promise.

Wang C, Wang J, Che S, Zhao H Heliyon. 2023; 9(11):e21776.

PMID: 38027932 PMC: 10658259. DOI: 10.1016/j.heliyon.2023.e21776.

Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies.

Abbasi S, Totmaj M, Abbasi M, Hajazimian S, Goleij P, Behroozi J Cancer Med. 2022; 12(7):7844-7858.

PMID: 36583504 PMC: 10134288. DOI: 10.1002/cam4.5551.

Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report.

Li Z, Meng F, Li J, Wu T Front Immunol. 2022; 13:931452.

PMID: 35903089 PMC: 9314645. DOI: 10.3389/fimmu.2022.931452.

CAR-NK Cells: From Natural Basis to Design for Kill.

Khawar M, Sun H Front Immunol. 2021; 12:707542.

PMID: 34970253 PMC: 8712563. DOI: 10.3389/fimmu.2021.707542.